FIELD: medicine; pharmaceuticals.
SUBSTANCE: invention relates to pharmaceutical industry, namely to a process for the preparation of a peptide agent having an anti-lithogenic effect. Process for the preparation of a peptide agent having an anti-lethogenic effect, wherein the lyophilized dried porcine kidney homogenate is extracted with acetic acid with intermittent stirring, then extract is frozen and then immediately thawed and filtered successively through a filter, the peptides are precipitated with acetone, then precipitate is separated by decantation and centrifugation, the precipitate is collected, dissolved in distilled water, the precipitate of the impurities in the secondary extract is filtered off, the supernatant is subsequently evaporated and dried under certain conditions.
EFFECT: above described method allows to obtain a preparation with a pronounced antilithogenic effect.
1 cl, 5 dwg, 2 ex
Title | Year | Author | Number |
---|---|---|---|
AGENT ANTILITAL POSSESSING ANTILITOGENIC ACTION | 2012 |
|
RU2484834C1 |
PHARMACOLOGICAL AGENT FOR URINARY STONE DISEASE TREATMENT | 2018 |
|
RU2679120C1 |
METHOD OF PROTEOMIC CORRECTION OF OXALATE NEPHROLITHIASIS | 2019 |
|
RU2704022C1 |
REMEDY FOR THE TREATMENT OF URATE NEPHROLITHIASIS | 2021 |
|
RU2762139C1 |
PHARMACOLOGICAL AGENT FOR THE TREATMENT OF URATE NEPHROPATHY | 2021 |
|
RU2760949C1 |
REMEDY FOR THE TREATMENT OF GASTRIC ULCER | 2018 |
|
RU2687561C1 |
METHOD FOR PREDICTING URATE NEPHROLITHIASIS | 2021 |
|
RU2759237C1 |
METHOD FOR PREDICTION OF URINARY STONE DISEASE | 2010 |
|
RU2451935C1 |
AGENT FOR CORRECTION OF ACUTE RENAL INSUFFICIENCY IN TOXIC HEPATORENAL SYNDROME INDUCED BY CARBON TETRACHLORIDE AND METHOD FOR CORRECTION OF ACUTE RENAL INSUFFICIENCY IN TOXIC HEPATORENAL SYNDROME INDUCED BY CARBON TETRACHLORIDE | 2004 |
|
RU2290940C2 |
PHYTOAGENT "NEFROLIT" FOR TREATMENT AND PROPHYLAXIS OF UROLITHIASIS DISEASE | 2002 |
|
RU2218170C1 |
Authors
Dates
2018-04-25—Published
2017-02-06—Filed